CTI BioPharma

$2.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-5.81%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell CTI BioPharma and other stocks, options, and ETFs commission-free!

About CTIC

CTI BioPharma Corp. (DE) Common Stock, also called CTI BioPharma, is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers.

CEO
Adam R. Craig
Employees
23
Headquarters
Seattle, Washington
Founded
1991
Market Cap
230.69M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.46M
High Today
$2.55
Low Today
$2.42
Open Price
$2.55
Volume
1.15M
52 Week High
$4.13
52 Week Low
$0.86

CTIC Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

FLZA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure